Quality and cost of healthcare services in patients with diabetes in Iran: Results of a nationwide short-term longitudinal survey.

care quality care standard diabetes mellitus healthcare utilization patient care continuity patient journey

Journal

Frontiers in endocrinology
ISSN: 1664-2392
Titre abrégé: Front Endocrinol (Lausanne)
Pays: Switzerland
ID NLM: 101555782

Informations de publication

Date de publication:
2023
Historique:
received: 15 11 2022
accepted: 14 02 2023
medline: 4 4 2023
entrez: 3 4 2023
pubmed: 4 4 2023
Statut: epublish

Résumé

To investigate the journey of patients with diabetes in the healthcare system using nationally-representative patient-reported data. Participants were recruited using a machine-learning-based sampling method based on healthcare structures and medical outcome data and were followed up for three months. We assessed the resource utilization, direct/indirect costs, and quality of healthcare services. One hundred fifty-eight patients with diabetes participated. The most utilized services were medication purchases (276 times monthly) and outpatient visits (231 times monthly). During the previous year, 90% of respondents had a laboratory fasting blood glucose assessment; however, less than 70% reported a quarterly follow-up physician visit. Only 43% had been asked about any hypoglycemia episodes by their physician. Less than 45% of respondents had been trained for hypoglycemia self-management. The annual average health-related direct cost of a patient with diabetes was 769 USD. The average out-of-pocket share of direct costs was 601 USD (78.15%). Medication purchases, inpatient services, and outpatient services summed up 79.77% of direct costs with a mean of 613 USD. Healthcare services focused solely on glycemic control and the continuity of services for diabetes control was insufficient. Medication purchases, and inpatient and outpatient services imposed the most out-of-pocket costs.

Identifiants

pubmed: 37008899
doi: 10.3389/fendo.2023.1099464
pmc: PMC10060949
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1099464

Informations de copyright

Copyright © 2023 Abbasi-Kangevari, Mohebi, Ghamari, Modirian, Shahbal, Ahmadi, Farzi, Azmin, Roshani, Zokaei, Khezrian, Seyfi, Keykhaei, Gorgani, Rahimi, Rezaei, Khatibzadeh and Shahraz.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

Am J Med. 2004 Nov 15;117(10):762-74
pubmed: 15541326
J Immigr Minor Health. 2011 Oct;13(5):967-9
pubmed: 21264514
Lancet. 2018 Feb 10;391(10120):541-551
pubmed: 29221645
Lancet Diabetes Endocrinol. 2022 Jan;10(1):8-10
pubmed: 34838158
Sci Rep. 2020 Sep 8;10(1):14790
pubmed: 32901098
Diabetes Care. 2016 Sep;39(9):e145-6
pubmed: 27335318
Lancet. 2012 Jan 7;379(9810):47-54
pubmed: 22169105
JAMA. 2005 Jan 12;293(2):217-28
pubmed: 15644549
Ann Glob Health. 2015 Nov-Dec;81(6):839-50
pubmed: 27108151
Diabetes Care. 2015 Aug;38(8):1583-91
pubmed: 26207052
Med Clin North Am. 2018 Jan;102(1):183-197
pubmed: 29156185
Diabetes Res Clin Pract. 2014 Feb;103(2):137-49
pubmed: 24630390
BMC Public Health. 2021 Jul 17;21(1):1414
pubmed: 34273940
Lancet Diabetes Endocrinol. 2017 Jun;5(6):423-430
pubmed: 28456416
BMJ Glob Health. 2019 Feb 27;4(1):e001258
pubmed: 30899566
Can J Diabetes. 2013 Apr;37 Suppl 1:S8-11
pubmed: 24070969
Diabetes Res Clin Pract. 2020 Apr;162:108072
pubmed: 32061820
Lancet Healthy Longev. 2021 Jun;2(6):e340-e351
pubmed: 35211689
BMC Public Health. 2020 Mar 19;20(1):359
pubmed: 32188428
J Diabetes Metab Disord. 2022 Jan 6;21(1):817-822
pubmed: 35673493
BMJ. 2019 Mar 27;364:l969
pubmed: 30917970
Hum Vaccin Immunother. 2018;14(11):2715-2721
pubmed: 29995561
BMJ Open. 2015 Aug 12;5(8):e008152
pubmed: 26270946
PLoS One. 2011;6(10):e26864
pubmed: 22066013
Diabetes Res Clin Pract. 2018 Apr;138:271-281
pubmed: 29496507
PLoS Med. 2020 Nov 12;17(11):e1003434
pubmed: 33180775
JAMA. 2021 Aug 24;326(8):744-760
pubmed: 34427595
J Diabetes Investig. 2017 Sep;8(5):701-708
pubmed: 28109182
J Telemed Telecare. 2019 Aug;25(7):402-413
pubmed: 29909748
JAMA Netw Open. 2022 Jan 4;5(1):e2140371
pubmed: 35029667
JAMA. 2017 Nov 14;318(18):1825-1827
pubmed: 29136434
Front Pharmacol. 2020 Aug 12;11:1176
pubmed: 32903568
J Clin Transl Endocrinol. 2016 Dec 09;7:21-27
pubmed: 29067246
BMC Health Serv Res. 2020 Jun 12;20(1):534
pubmed: 32532266
Diabetes Ther. 2021 Nov;12(11):2921-2938
pubmed: 34595726
East Mediterr Health J. 2021 Jul 29;27(7):656-664
pubmed: 34369579
Diabetes Res Clin Pract. 2020 Dec;170:108522
pubmed: 33096187
Lancet. 2021 Dec 19;396(10267):2019-2082
pubmed: 33189186
Lancet. 2020 Oct 17;396(10258):1204-1222
pubmed: 33069326
PLoS Med. 2019 Mar 1;16(3):e1002751
pubmed: 30822339
Arch Iran Med. 2017 Sep;20(9):608-616
pubmed: 29048923
Sci Rep. 2017 Oct 18;7(1):13461
pubmed: 29044139
PLoS One. 2012;7(8):e44526
pubmed: 22952989

Auteurs

Mohsen Abbasi-Kangevari (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Farnam Mohebi (F)

Haas School of Business, University of California Berkeley, Berkeley, CA, United States.

Seyyed-Hadi Ghamari (SH)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mitra Modirian (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Nazila Shahbal (N)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Naser Ahmadi (N)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Yosef Farzi (Y)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mehrdad Azmin (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Shahin Roshani (S)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
The Netherlands Cancer Institute (NKI), Amsterdam, Netherlands.

Hossein Zokaei (H)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Maryam Khezrian (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Shahedeh Seyfi (S)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Mohammad Keykhaei (M)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Feinberg Cardiovascular and Renal Research Institute, Northwestern University, School of Medicine, Chicago, IL, United States.

Fatemeh Gorgani (F)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Saral Rahimi (S)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Negar Rezaei (N)

Non-Communicable Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Endocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Shahab Khatibzadeh (S)

Heller School for Social Policy and Management, Brandeis University, Waltham, MA, United States.

Saeid Shahraz (S)

Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, Boston, MA, United States.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH